Nuvalent, Inc. 4

Deerfield-affiliated funds and James E. Flynn jointly reported changes in their beneficial ownership of Nuvalent, Inc. on a Form 4 dated July 15, 2026, but this exhibit does not contain the transaction details.

This filing is a joint filer information exhibit indicating that multiple Deerfield investment entities, together with designated filer James E. Flynn, are jointly reporting changes in beneficial ownership of Nuvalent, Inc. (NUVL) on a related Form 4 dated July 15, 2026. The document itself does not specify the nature, size, or pricing of any underlying transactions, but rather formalizes that Deerfield Mgmt, L.P. and affiliated funds are aggregating and reporting their holdings and transactions in Nuvalent through Flynn as the designated filer. Without the accompanying Form 4 tables, the specific buy/sell activity, share counts, and dollar amounts cannot be determined from this exhibit alone.

Filing Facts

CIK

1861560

Ticker

NUVL

Form

4

Source Type

fda

Accession

0001193805-26-000978

Alert Tier

4